The document is a Balliau valuation report on NXS ...hopefully the NXS website will have it in the next few daysI get them emailed to me from Ballieau
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025